Hemodynamic regulation of reactive oxygen species: Implications for vascular diseases

Antioxidants and Redox Signaling

Volumn 20, Issue 6, 2014, Pages 914-928

  Raaz, Uwe ^a   Toh, Ryuji ^a   Maegdefessel, Lars ^a,b   Adam, Matti ^a   Nakagami, Futoshi ^a   Emrich, Fabian C ^a   Spin, Joshua M ^a   Tsao, Philip S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; HEMODYNAMICS; HUMANS; REACTIVE OXYGEN SPECIES; STRESS, MECHANICAL; VASCULAR DISEASES;

EID: 84893841039     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5507     Document Type: Review

References (134)

1. Ali MH, Pearlstein DP, Mathieu CE, and Schumacker PT. Mitochondrial requirement for endothelial responses to cyclic strain: implications for mechanotransduction. Am J Physiol Lung Cell Mol Physiol 287: L486-L496, 2004. (Pubitemid 39095903)
2. Andrew PJ and Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res 43: 521-531, 1999. (Pubitemid 29369251)
3. Aoki T, Nishimura M, Kataoka H, Ishibashi R, Nozaki K, and Hashimoto N. Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox(-/-) mice. Lab Invest 89: 730-741, 2009.
4. Arnold WP, Mittal CK, Katsuki S, and Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3¢:5¢-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 74: 3203-3207, 1977. (Pubitemid 8180317)
5. Asplund K. Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med 251: 372-392, 2002. (Pubitemid 34534113)
6. Azevedo LC, Pedro MA, Souza LC, de Souza HP, Janiszewski M, da Luz PL, and Laurindo FR. Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc Res 47: 436-445, 2000. (Pubitemid 30646066)
7. Bae YS, Lee JH, Choi SH, Kim S, Almazan F, Witztum JL, and Miller YI. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4-and spleen tyrosine kinasedependent activation of NADPH oxidase 2. Circ Res 104: 210-218, 2009.
8. Barauna VG, Magalhaes FC, Campos LC, Reis RI, Kunapuli SP, Costa-Neto CM, Miyakawa AA, and Krieger JE. Shear stress-induced Ang II AT1 receptor activation: G-protein dependent and independent mechanisms. Biochem Biophys Res Commun 434: 647-652, 2013.
9. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, and Runge MS. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 108: 1513-1522, 2001. (Pubitemid 33091989)
10. Beckman JS, Beckman TW, Chen J, Marshall PA, and Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624, 1990.
11. Bendall JK, Rinze R, Adlam D, Tatham AL, de Bono J, Wilson N, Volpi E, and Channon KM. Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice. Circ Res 100: 1016-1025, 2007. (Pubitemid 46598926)
12. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, and Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85: 1260-1266, 1990. (Pubitemid 20123772)
13. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, and Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37: 781-786, 2001. (Pubitemid 32199066)
14. Bhullar IS, Li YS, Miao H, Zandi E, Kim M, Shyy JY, and Chien S. Fluid shear stress activation of IkappaB kinase is integrin-dependent. J Biol Chem 273: 30544-30549, 1998. (Pubitemid 28545531)
15. Birukov KG. Cyclic stretch, reactive oxygen species, and vascular remodeling. Antioxid Redox Signal 11: 1651-1667, 2009.
16. Bleys J, Miller ERr, Pastor-Barriuso R, Appel LJ, and Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr 84: 880-887; quiz 954-955, 2006. (Pubitemid 44715671)
17. Brandes RP, Takac I, and Schroder K
18. Briones AM, Arribas SM, and Salaices M. Role of extracellular matrix in vascular remodeling of hypertension. Curr Opin Nephrol Hypertens 19: 187-194, 2010.
19. Brown MR, Miller FJJ, Li WG, Ellingson AN, Mozena JD, Chatterjee P, Engelhardt JF, Zwacka RM, Oberley LW, Fang X, Spector AA, and Weintraub NL. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ Res 85: 524-533, 1999. (Pubitemid 29431953)
20. Browning EA, Chatterjee S, and Fisher AB. Stop the flow: a paradigm for cell signaling mediated by reactive oxygen species in the pulmonary endothelium. Annu Rev Physiol 74: 403-424, 2012.
21. Cai H and Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
22. Castier Y, Brandes RP, Leseche G, Tedgui A, and Lehoux S. p47phox-dependent NADPH oxidase regulates flowinduced vascular remodeling. Circ Res 97: 533-540, 2005. (Pubitemid 41361743)
23. Castier Y, Ramkhelawon B, Riou S, Tedgui A, and Lehoux S. Role of NF-kappaB in flow-induced vascular remodeling. Antioxid Redox Signal 11: 1641-1649, 2009.
24. Chapman GB, Durante W, Hellums JD, and Schafer AI. Physiological cyclic stretch causes cell cycle arrest in cultured vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 278: H748-H754, 2000. (Pubitemid 30152530)
25. Chen CA, Wang TY, Varadharaj S, Reyes LA, Hemann C, Talukder MA, Chen YR, Druhan LJ, and Zweier JL. Sglutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 468: 1115-1118, 2010.
26. Chen XL, Tummala PE, Olbrych MT, Alexander RW, and Medford RM. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 83: 952-959, 1998. (Pubitemid 28503085)
27. Cheng JJ, Wung BS, Chao YJ, and Wang DL. Cyclic straininduced reactive oxygen species involved in ICAM-1 gene induction in endothelial cells. Hypertension 31: 125-130, 1998. (Pubitemid 28124704)
28. Commoner B, Townsend J, and Pake GE. Free radicals in biological materials. Nature 174: 689-691, 1954.
29. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, and Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 82: 1094-1101, 1998. (Pubitemid 28249070)
30. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, and Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 45: 1340-1351, 2008.
31. Dikalova A, Clempus R, Lassegue B, Cheng G, McCoy J, Dikalov S, San Martin A, Lyle A, Weber DS, Weiss D, Taylor WR, Schmidt HH, Owens GK, Lambeth JD, and Griendling KK. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112: 2668-2676, 2005. (Pubitemid 41532604)
32. Dikalova AE, Gongora MC, Harrison DG, Lambeth JD, Dikalov S, and Griendling KK. Upregulation of Nox1 in vascular smooth muscle leads to impaired endotheliumdependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol 299: H673-H679, 2010.
33. Dimmeler S, Hermann C, Galle J, and Zeiher AM. Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol 19: 656-664, 1999. (Pubitemid 29135168)
34. Dubick MA, Hunter GC, Casey SM, and Keen CL. Aortic ascorbic acid, trace elements, and superoxide dismutase activity in human aneurysmal and occlusive disease. Proc Soc Exp Biol Med 184: 138-143, 1987. (Pubitemid 17022084)
35. Dubick MA, Keen CL, DiSilvestro RA, Eskelson CD, Ireton J, and Hunter GC. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc Soc Exp Biol Med 220: 39-45, 1999.
36. Ejiri J, Inoue N, Tsukube T, Munezane T, Hino Y, Kobayashi S, Hirata K, Kawashima S, Imajoh-Ohmi S, Hayashi Y, Yokozaki H, Okita Y, and Yokoyama M. Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker. Cardiovasc Res 59: 988-996, 2003. (Pubitemid 38366255)
37. Finkel T and Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247, 2000.
38. Fiorani M, Cantoni O, Tasinato A, Boscoboinik D, and Azzi A. Hydrogen peroxide-and fetal bovine serum-induced DNA synthesis in vascular smooth muscle cells: positive and negative regulation by protein kinase C isoforms. Biochim Biophys Acta 1269: 98-104, 1995.
39. Fisher AB. Redox signaling across cell membranes. Antioxid Redox Signal 11: 1349-1356, 2009.
40. Forman HJ, Torres M, and Fukuto J. Redox signaling. Mol Cell Biochem 234-235: 49-62, 2002. (Pubitemid 34777841)
41. Forstermann U. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol Chem 387: 1521-1533, 2006. (Pubitemid 44837576)
42. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, and Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 105: 1631-1639, 2000.
43. Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, and Krause KH. Decreased blood pressure in NOX1-deficient mice. FEBS Lett 580: 497-504, 2006. (Pubitemid 43089678)
44. Gavrila D, Li WG, McCormick ML, Thomas M, Daugherty A, Cassis LA, Miller FJJ, Oberley LW, Dellsperger KC, and Weintraub NL. Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25: 1671-1677, 2005. (Pubitemid 41098939)
45. Godbole AS, Lu X, Guo X, and Kassab GS. NADPH oxidase has a directional response to shear stress. Am J Physiol Heart Circ Physiol 296: H152-H158, 2009.
46. Goettsch C, Goettsch W, Arsov A, Hofbauer LC, Bornstein SR, and Morawietz H. Long-term cyclic strain downregulates endothelial Nox4. Antioxid Redox Signal 11: 2385-2397, 2009.
47. Goettsch C, Goettsch W, Brux M, Haschke C, Brunssen C, Muller G, Bornstein SR, Duerrschmidt N, Wagner AH, and Morawietz H. Arterial flow reduces oxidative stress via an antioxidant response element and Oct-1 binding site within the NADPH oxidase 4 promoter in endothelial cells. Basic Res Cardiol 106: 551-561, 2011.
48. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994. (Pubitemid 24176909)
49. Grote K, Flach I, Luchtefeld M, Akin E, Holland SM, Drexler H, and Schieffer B. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidasederived reactive oxygen species. Circ Res 92: e80-e86, 2003.
50. Gryglewski RJ, Palmer RM, and Moncada S. Superoxide anion is involved in the breakdown of endotheliumderived vascular relaxing factor. Nature 320: 454-456, 1986. (Pubitemid 16097810)
51. Guzik TJ, Chen W, Gongora MC, Guzik B, Lob HE, Mangalat D, Hoch N, Dikalov S, Rudzinski P, Kapelak B, Sadowski J, and Harrison DG. Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol 52: 1803-1809, 2008.
52. Guzik TJ, Sadowski J, Guzik B, Jopek A, Kapelak B, Przybylowski P, Wierzbicki K, Korbut R, Harrison DG, and Channon KM. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 26: 333-339, 2006. (Pubitemid 43732196)
53. Harrison R. Physiological roles of xanthine oxidoreductase. Drug Metab Rev 36: 363-375, 2004. (Pubitemid 38802492)
54. Hay D. Activation of NF-jB nuclear transcription factor by flow in human endothelial cells. Biochim Biophys Acta Mol Cell Res 1642: 33-44, 2003. (Pubitemid 37338276)
55. Hipper A and Isenberg G. Cyclic mechanical strain decreases the DNA synthesis of vascular smooth muscle cells. Pflugers Arch 440: 19-27, 2000. (Pubitemid 30265906)
56. Howard AB, Alexander RW, Nerem RM, Griendling KK, and Taylor WR. Cyclic strain induces an oxidative stress in endothelial cells. Am J Physiol 272: C421-C427, 1997.
57. Hsich E, Segal BH, Pagano PJ, Rey FE, Paigen B, Deleonardis J, Hoyt RF, Holland SM, and Finkel T. Vascular effects following homozygous disruption of p47phox: an essential component of NADPH Oxidase. Circulation 101: 1234-1236, 2000. (Pubitemid 30158608)
58. Hsieh HJ, Cheng CC, Wu ST, Chiu JJ, Wung BS, and Wang DL. Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shearinduced c-fos expression. J Cell Physiol 175: 156-162, 1998. (Pubitemid 28140672)
59. Hwang J, Ing MH, Salazar A, Lassegue B, Griendling K, Navab M, Sevanian A, and Hsiai TK. Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ Res 93: 1225-1232, 2003. (Pubitemid 37543063)
60. Hwang J, Saha A, Boo YC, Sorescu GP, McNally JS, Holland SM, Dikalov S, Giddens DP, Griendling KK, and Harrison DG, Jo H. Oscillatory shear stress stimulates endothelial production of O2-from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem 278: 47291-47298, 2003. (Pubitemid 37452318)
61. Inoue N, Ramasamy S, Fukai T, Nerem RM, and Harrison DG. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res 79: 32-37, 1996. (Pubitemid 26196314)
62. Judkins CP, Diep H, Broughton BR, Mast AE, Hooker EU, Miller AA, Selemidis S, Dusting GJ, Sobey CG, and Drummond GR. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/-mice. Am J Physiol Heart Circ Physiol 298: H24-H32, 2010.
63. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, and Brandes RP. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109: 1795-1801, 2004. (Pubitemid 38500684)
64. Khatri JJ, Johnson C, Magid R, Lessner SM, Laude KM, Dikalov SI, Harrison DG, Sung HJ, Rong Y, and Galis ZS. Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 109: 520-525, 2004. (Pubitemid 38168516)
65. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, and LeBoeuf RC. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20: 1529-1535, 2000. (Pubitemid 30353884)
66. Kojda G and Hambrecht R. Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 67: 187-197, 2005. (Pubitemid 40943611)
67. Ku DN, Giddens DP, Zarins CK, and Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arterioscler Thromb Vasc Biol 5: 293-302, 1985. (Pubitemid 15098005)
68. Laurindo FR, Pedro Mde A, Barbeiro HV, Pileggi F, Carvalho MH, Augusto O, and da Luz PL. Vascular free radical release. Ex vivo and in vivo evidence for a flowdependent endothelial mechanism. Circ Res 74: 700-709, 1994.
69. Lee CF, Qiao M, Schroder K, Zhao Q, and Asmis R. Nox4 is a novel inducible source of reactive oxygen species in monocytes and macrophages and mediates oxidized low density lipoprotein-induced macrophage death. Circ Res 106: 1489-1497, 2010.
70. Lee MY, San Martin A, Mehta PK, Dikalova AE, Garrido AM, Datla SR, Lyons E, Krause KH, Banfi B, Lambeth JD, Lassegue B, and Griendling KK. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 29: 480-487, 2009.
71. Lehoux S and Tedgui A. Signal transduction of mechanical stresses in the vascular wall. Hypertension 32: 338-345, 1998. (Pubitemid 28376494)
72. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, and Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension 37: 541-546, 2001. (Pubitemid 32199025)
73. Li PF, Dietz R, and von Harsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett 404: 249-252, 1997. (Pubitemid 27113462)
74. Lin Y, Liu X, Cheng Y, Yang J, Huo Y, and Zhang C. Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J Biol Chem 284: 7903-7913, 2009.
75. Liu JQ, Zelko IN, Erbynn EM, Sham JS, and Folz RJ. Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). Am J Physiol Lung Cell Mol Physiol 290: L2-L10, 2006.
76. Loukogeorgakis SP, van den Berg MJ, Sofat R, Nitsch D, Charakida M, Haiyee B, de Groot E, MacAllister RJ, Kuijpers TW, and Deanfield JE. Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans. Circulation 121: 2310-2316, 2010.
77. Lu X, Guo X, Wassall CD, Kemple MD, Unthank JL, and Kassab GS. Reactive oxygen species cause endothelial dysfunction in chronic flow overload. J Appl Physiol 110: 520-527, 2011.
78. Luchtefeld M, Grote K, Grothusen C, Bley S, Bandlow N, Selle T, Struber M, Haverich A, Bavendiek U, Drexler H, and Schieffer B. Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun 328: 183-188, 2005. (Pubitemid 40164653)
79. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassegue B, and Griendling KK. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105: 249-259, 2009.
80. MacSweeney ST, Young G, Greenhalgh RM, and Powell JT. Mechanical properties of the aneurysmal aorta. Br J Surg 79: 1281-1284, 1992. (Pubitemid 23008377)
81. Maegdefessel L, Azuma J, Toh R, Deng A, Merk DR, Raiesdana A, Leeper NJ, Raaz U, Schoelmerich AM, McConnell MV, Dalman RL, Spin JM, and Tsao PS. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci Transl Med 4: 122ra22, 2012.
82. Maegdefessel L, Azuma J, Toh R, Merk DR, Deng A, Chin JT, Raaz U, Schoelmerich AM, Raiesdana A, Leeper NJ, McConnell MV, Dalman RL, Spin JM, and Tsao PS. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 122: 497-506, 2012.
83. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, and Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18: 69-82, 2006. (Pubitemid 41415716)
84. Matsushita H, Lee KH, and Tsao PS. Cyclic strain induces reactive oxygen species production via an endothelial NAD(P)H oxidase. J Cell Biochem Suppl Suppl 36: 99-106, 2001.
85. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, Jo H, and Harrison DG. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 285: H2290-H2297, 2003. (Pubitemid 37443044)
86. Miller FJ. Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol 22: 560-565, 2002.
87. Minor RLJ, Myers PR, Guerra RJ, Bates JN, and Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 86: 2109-2116, 1990.
88. Miura H. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 92: 31e-40e, 2002.
89. Mohan S, Koyoma K, Thangasamy A, Nakano H, Glickman RD, and Mohan N. Low shear stress preferentially enhances IKK activity through selective sources of ROS for persistent activation of NF-kappaB in endothelial cells. Am J Physiol Cell Physiol 292: C362-C371, 2007. (Pubitemid 46115144)
90. Mohan S, Mohan N, and Sprague EA. Differential activation of NF-kappa B in human aortic endothelial cells conditioned to specific flow environments. Am J Physiol 273: C572-C578, 1997.
91. Mueller CF, Widder JD, McNally JS, McCann L, Jones DP, and Harrison DG. The role of the multidrug resistance protein-1 in modulation of endothelial cell oxidative stress. Circ Res 97: 637-644, 2005. (Pubitemid 41416332)
92. Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, and Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res 69: 1293-1300, 1991.
93. Muller G and Morawietz H. Nitric oxide, NAD(P)H oxidase, and atherosclerosis. Antioxid Redox Signal 11: 1711-1731, 2009.
94. Nakahashi TK, Hoshina K, Tsao PS, Sho E, Sho M, Karwowski JK, Yeh C, Yang RB, Topper JN, and Dalman RL. Flow loading induces macrophage antioxidative gene expression in experimental aneurysms. Arterioscler Thromb Vasc Biol 22: 2017-2022, 2002. (Pubitemid 36025208)
95. Nigro P, Abe J, and Berk BC. Flow shear stress and atherosclerosis: a matter of site specificity. Antioxid Redox Signal 15: 1405-1414, 2011.
96. Nishio E and Watanabe Y. The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br J Pharmacol 121: 665-670, 1997. (Pubitemid 27260768)
97. Oeckler RA. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogenactivated protein kinase cascade. Circ Res 92: 23-31, 2002. (Pubitemid 36105603)
98. Pacher P, Beckman JS, and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007. (Pubitemid 46217686)
99. Palmer RM, Ferrige AG, and Moncada S. Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature 327: 524-526, 1987. (Pubitemid 17085822)
100. Paravicini TM, Miller AA, Drummond GR, and Sobey CG. Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol-3 kinase, NADPH-oxidase, and nitric oxide synthase. J Cereb Blood Flow Metab 26: 836-845, 2006.
101. Park YM, Febbraio M, and Silverstein RL. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 119: 136-145, 2009.
102. Petersen OH, Michalak M, and Verkhratsky A. Calcium signalling: past, present and future. Cell Calcium 38: 161-169, 2005. (Pubitemid 41283257)
103. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal J-F, and Michel J-B. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-b activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 20: 645-651, 2000. (Pubitemid 30151676)
104. Raaz U, Kuhn H, Wirtz H, and Hammerschmidt S. Rapamycin reduces high-amplitude, mechanical stretch-induced apoptosis in pulmonary microvascular endothelial cells. Microvasc Res 77: 297-303, 2009.
105. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, and Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98: 2572-2579, 1996. (Pubitemid 26415078)
106. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
107. Ramkhelawon B, Rivas D, and Lehoux S. Shear stress activates extracellular signal-regulated kinase 1/2 via the angiotensin II type 1 receptor. FASEB J 27: 3008-3016, 2013.
108. Ray R, Murdoch CE, Wang M, Santos CX, Zhang M, Alom-Ruiz S, Anilkumar N, Ouattara A, Cave AC, Walker SJ, Grieve DJ, Charles RL, Eaton P, Brewer AC, and Shah AM. Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler Thromb Vasc Biol 31: 1368-1376, 2011.
109. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, and Saez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41: 1096-1101, 2003. (Pubitemid 36548609)
110. Rosen GM, Pou S, Ramos CL, Cohen MS, and Britigan BE. Free radicals and phagocytic cells. FASEB J 9: 200-209, 1995.
111. Rueckschloss U, Galle J, Holtz J, Zerkowski H-R, and Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme a reductase inhibitor therapy. Circulation 104: 1767-1772, 2001. (Pubitemid 32963340)
112. Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiker-Kleiner D, and Drexler H. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 87: 1195-1201, 2000.
113. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Forro L, Schlegel W, and Krause KH. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406: 105-114, 2007. (Pubitemid 47264740)
114. Sheehan AL, Carrell S, Johnson B, Stanic B, Banfi B, and Miller FJJ. Role for Nox1 NADPH oxidase in atherosclerosis. Atherosclerosis 216: 321-326, 2011.
115. Shi Y, Niculescu R, Wang D, Patel S, Davenpeck KL, and Zalewski A. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol 21: 739-745, 2001. (Pubitemid 32448762)
116. Small EM, Frost RJ, and Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation 121: 1022-1032, 2010.
117. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, and Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105: 1429-1435, 2002. (Pubitemid 34263273)
118. Stocker R and Keaney JFJ. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381-1478, 2004. (Pubitemid 39302636)
119. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, and Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401: 79-82, 1999.
120. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
121. Sutherland EW. Studies on the mechanism of hormone action. Science 177: 401-408, 1972.
122. Szocs K. Upregulation of Nox-Based NAD(P)H Oxidases in Restenosis After Carotid Injury. Arterioscler Thromb Vasc Biol 22: 21-27, 2002. (Pubitemid 34076227)
123. Tabet F, Schiffrin EL, Callera GE, He Y, Yao G, Ostman A, Kappert K, Tonks NK, and Touyz RM. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR. Circ Res 103: 149-158, 2008.
124. Takabe W, Warabi E, and Noguchi N. Anti-atherogenic effect of laminar shear stress via Nrf2 activation. Antioxid Redox Signal 15: 1415-1426, 2011.
125. Thomas M, Gavrila D, McCormick ML, Miller FJJ, Daugherty A, Cassis LA, Dellsperger KC, and Weintraub NL. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein Edeficient mice. Circulation 114: 404-413, 2006. (Pubitemid 44264822)
126. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, and Pritchard KAJ. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95: 9220-9225, 1998. (Pubitemid 28506212)
127. Vecchione C, Carnevale D, Di Pardo A, Gentile MT, Damato A, Cocozza G, Antenucci G, Mascio G, Bettarini U, Landolfi A, Iorio L, Maffei A, and Lembo G. Pressureinduced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway. Hypertension 54: 1028-1034, 2009.
128. Virdis A, Neves MF, Amiri F, Touyz RM, and Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 22: 535-542, 2004. (Pubitemid 38368487)
129. Wei Z, Costa K, Al-Mehdi AB, Dodia C, Muzykantov V, and Fisher AB. simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. Circ Res 85: 682-689, 1999. (Pubitemid 29480808)
130. Willett NJ, Kundu K, Knight SF, Dikalov S, Murthy N, and Taylor WR. Redox signaling in an in vivo murine model of low magnitude oscillatory wall shear stress. Antioxid Redox Signal 15: 1369-1378, 2011.
131. Williams B. Mechanical influences on vascular smooth muscle cell function. J Hypertens 16: 1921-1929, 1998. (Pubitemid 29002369)
132. Xiong W, Mactaggart J, Knispel R, Worth J, Zhu Z, Li Y, Sun Y, Baxter BT, and Johanning J. Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model. Atherosclerosis 202: 128-134, 2009.
133. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, Taylor WR, and Griendling KK. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin IIinduced vascular hypertrophy. Hypertension 32: 488-495, 1998. (Pubitemid 28429138)
134. Zhang Q, Malik P, Pandey D, Gupta S, Jagnandan D, Belin de Chantemele E, Banfi B, Marrero MB, Rudic RD, Stepp DW, and Fulton DJ. Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase. Arterioscler Thromb Vasc Biol 28: 1627-1633, 2008.